Eva Kumlien

4.1k total citations
75 papers, 2.3k citations indexed

About

Eva Kumlien is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eva Kumlien has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Psychiatry and Mental health, 24 papers in Cellular and Molecular Neuroscience and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eva Kumlien's work include Epilepsy research and treatment (41 papers), Pharmacological Effects and Toxicity Studies (22 papers) and Neuroscience and Neuropharmacology Research (18 papers). Eva Kumlien is often cited by papers focused on Epilepsy research and treatment (41 papers), Pharmacological Effects and Toxicity Studies (22 papers) and Neuroscience and Neuropharmacology Research (18 papers). Eva Kumlien collaborates with scholars based in Sweden, United States and United Kingdom. Eva Kumlien's co-authors include Johan Zelano, Peter Mattsson, P. O. Lundberg, Bengt Långström, David Fällmar, Kristina Malmgren, Elham Rostami, Torbjörn Tomson, Johan Virhammar and Mats Ericson and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Neurology.

In The Last Decade

Eva Kumlien

73 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Kumlien Sweden 28 1.2k 719 715 641 284 75 2.3k
Angus A. Wilfong United States 28 1.3k 1.1× 442 0.6× 650 0.9× 684 1.1× 90 0.3× 67 2.7k
Mar Carreño Spain 27 1.4k 1.1× 514 0.7× 790 1.1× 565 0.9× 93 0.3× 116 2.1k
Kenji Sugai Japan 27 1.0k 0.9× 296 0.4× 760 1.1× 552 0.9× 239 0.8× 213 2.8k
Çiğdem Özkara Türkiye 27 1.5k 1.3× 294 0.4× 872 1.2× 616 1.0× 94 0.3× 128 2.4k
Katherine Nickels United States 28 1.7k 1.4× 566 0.8× 956 1.3× 634 1.0× 71 0.3× 79 2.6k
Y Hart United Kingdom 17 1.4k 1.1× 414 0.6× 890 1.2× 582 0.9× 118 0.4× 30 2.0k
Luigi Maria Specchio Italy 26 1.7k 1.4× 350 0.5× 1.2k 1.7× 610 1.0× 79 0.3× 71 2.4k
Arjune Sen United Kingdom 24 1.1k 0.9× 324 0.5× 636 0.9× 694 1.1× 82 0.3× 87 2.2k
Eylert Brodtkorb Norway 35 1.9k 1.6× 473 0.7× 1.5k 2.1× 740 1.2× 120 0.4× 132 3.5k
Carlo Di Bonaventura Italy 26 1.1k 1.0× 347 0.5× 657 0.9× 571 0.9× 86 0.3× 141 1.9k

Countries citing papers authored by Eva Kumlien

Since Specialization
Citations

This map shows the geographic impact of Eva Kumlien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kumlien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kumlien more than expected).

Fields of papers citing papers by Eva Kumlien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kumlien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kumlien. The network helps show where Eva Kumlien may publish in the future.

Co-authorship network of co-authors of Eva Kumlien

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kumlien. A scholar is included among the top collaborators of Eva Kumlien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kumlien. Eva Kumlien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fahlström, Markus, et al.. (2025). Subcortical Brain Regions Associated With Seizure Risk in Patients With IDH Mutated Diffuse Gliomas. Brain and Behavior. 15(4). e70477–e70477.
2.
Lubberink, Mark, Lieuwe Appel, Xiaotian T. Fang, et al.. (2024). Evaluation of [11C]UCB-A positron emission tomography in human brains. EJNMMI Research. 14(1). 56–56.
3.
Taxiarchis, Apostolos, Bo‐Michael Bellander, Jovan P. Antović, et al.. (2023). Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID‐19 and neurological symptoms. International Journal of Laboratory Hematology. 46(1). 42–49. 5 indexed citations
4.
Andersson, My, et al.. (2023). Immune response in blood before and after epileptic and psychogenic non-epileptic seizures. Heliyon. 9(3). e13938–e13938. 7 indexed citations
5.
Vasaitis, Lilian, Johan Wikström, Olafur Gudjonsson, et al.. (2021). Histopathological findings in the landscape of IgG4‐related pathology in patients with pituitary dysfunction: Review of six cases. Journal of Neuroendocrinology. 33(3). e12942–e12942. 6 indexed citations
6.
Fällmar, David, Elham Rostami, Eva Kumlien, et al.. (2021). The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care. Journal of Neuroradiology. 49(6). 421–427. 12 indexed citations
7.
Malmgren, Kristina, et al.. (2019). Evaluation for epilepsy surgery – Why do patients not proceed to operation?. Seizure. 69. 241–244. 10 indexed citations
8.
Åsberg, Signild, et al.. (2018). Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study. Seizure. 64. 29–33. 19 indexed citations
9.
Sauro, Khara M., Samuel Wiebe, Colin Dunkley, et al.. (2015). The current state of epilepsy guidelines: A systematic review. Epilepsia. 57(1). 13–23. 50 indexed citations
10.
Sauro, Khara M., Samuel Wiebe, Timothy A. Pedley, et al.. (2015). Current State Of International Epilepsy Guidelines. Epilepsia. 56. 238–238. 1 indexed citations
11.
Zelano, Johan, et al.. (2014). Infections in status epilepticus: A retrospective 5-year cohort study. Seizure. 23(8). 603–606. 38 indexed citations
12.
Zelano, Johan & Eva Kumlien. (2012). Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: A systematic review. Seizure. 21(4). 233–236. 44 indexed citations
13.
Kumlien, Eva & Peter Mattsson. (2010). Attitudes towards epilepsy surgery: A nationwide survey among Swedish neurologists. Seizure. 19(4). 253–255. 72 indexed citations
14.
Kumlien, Eva & P. O. Lundberg. (2009). Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database. Seizure. 19(2). 69–73. 92 indexed citations
15.
Qu, Mingqi, Eleonora Aronica, Karin Boer, et al.. (2009). DLG3/SAP102 protein expression in malformations of cortical development: A study of human epileptic cortex by tissue microarray. Epilepsy Research. 84(1). 33–41. 16 indexed citations
16.
Samuelsson, Carolina, Timothy Howells, Eva Kumlien, et al.. (2008). Relationship between intracranial hemodynamics and microdialysis markers of energy metabolism and glutamate-glutamine turnover in subarachnoid hemorrhage patients.. Journal of neurosurgery. 2 indexed citations
17.
Mattsson, Peter, et al.. (2004). A prospective study of anxiety with respect to seizure outcome after epilepsy surgery. Seizure. 14(1). 40–45. 19 indexed citations
18.
Kumlien, Eva, Per Hartvig, Sven Valind, et al.. (1999). NMDA‐Receptor Activity Visualized with (S)‐[N‐Methyl‐11C]Ketamine and Positron Emission Tomography in Patients with Medial Temporal Lobe Epilepsy. Epilepsia. 40(1). 30–37. 62 indexed citations
19.
Kumlien, Eva. (1994). In vitro and in vivo studies on epileptogenic tissue in temporal lobe epilepsy. 1 indexed citations
20.
Kumlien, Eva, P. Hilton‐Brown, Bo Spännare, & Per‐Göran Gillberg. (1992). In Vitro Quantitative Autoradiography of [3H]‐L‐Deprenyl and [3H]‐PK 11195 Binding Sites in Human Epileptic Hippocampus. Epilepsia. 33(4). 610–617. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angus A. Wilfong Breakdown of academic impact, for papers by Mar Carreño Breakdown of academic impact, for papers by Kenji Sugai Breakdown of academic impact, for papers by Çiğdem Özkara Breakdown of academic impact, for papers by Katherine Nickels Breakdown of academic impact, for papers by Y Hart Breakdown of academic impact, for papers by Luigi Maria Specchio Breakdown of academic impact, for papers by Arjune Sen Breakdown of academic impact, for papers by Eylert Brodtkorb Breakdown of academic impact, for papers by Carlo Di Bonaventura
Rankless by CCL
2026